{
    "clinical_study": {
        "@rank": "167984", 
        "arm_group": [
            {
                "arm_group_label": "Atosiban", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receive a bolus injection of 6.75mg atosiban and following an atosibaninfusion at 18mg/u during 3 hours."
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Patients receive a placebo bolus injection (NaCl 0.9%)and an infusion of NaCl 0.9% during 3 hours"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study the investigators compare the usual way of embryo transfer (without\n      medication) with an embryo transfer while administering oxytocine antagonist. This to\n      improve implantation and increase the pregnancy rate."
        }, 
        "brief_title": "Oxytocin Antagonist in Patients With Repeated Failure of Implantation", 
        "condition": "Repeated Implantation Failure", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  IVF/ ICSI patients below 38 years\n\n          -  2e to 6e IVF-cycle\n\n        Exclusion Criteria:\n\n          -  patients with endocrinological diseases or problems"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "38 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "290", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01673399", 
            "org_study_id": "2012-000278-49"
        }, 
        "intervention": [
            {
                "arm_group_label": "Atosiban", 
                "description": "Bolus atosiban 6.75mg + infusion atosiban 18mg/u during 3 hours. once administered starting 1 hour before embryotransfer.", 
                "intervention_name": "Atosiban", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxytocin", 
                "Atosiban"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "repeated implantation failure", 
            "atosiban", 
            "pregnancy"
        ], 
        "lastchanged_date": "August 27, 2012", 
        "location": {
            "contact": {
                "email": "wim.decleer@janpalfijngent.be", 
                "last_name": "Wim Decleer, gynecologist", 
                "phone": "0032 9 2243024"
            }, 
            "contact_backup": {
                "email": "ivf.centrum@janpalfijngent.be", 
                "phone": "0032 9 2248850"
            }, 
            "facility": {
                "address": {
                    "city": "Gent", 
                    "country": "Belgium", 
                    "state": "Oost-vlaanderen", 
                    "zip": "9000"
                }, 
                "name": "AZ Jan Palfijn"
            }, 
            "investigator": {
                "last_name": "Wim Decleer, gynecologist", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Oxytocin Antagonist in Patients With Repeated Failure of Implantation. A Prospective Randomized Placebo-controlled Double-blind Study.", 
        "overall_contact": {
            "email": "wim.decleer@janpalfijngent.be", 
            "last_name": "Wim Decleer, gynecologist", 
            "phone": "0032 9 3259220"
        }, 
        "overall_contact_backup": {
            "email": "ivf.studie@janpalfijngent.be", 
            "last_name": "Paul Devroey, professor", 
            "phone": "0032 9 2248070"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the number of patients that show a positive blood pregnancy test", 
            "measure": "implantation rate", 
            "safety_issue": "No", 
            "time_frame": "16 days from eggretrieval"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01673399"
        }, 
        "responsible_party": {
            "investigator_affiliation": "AZ Jan Palfijn Gent", 
            "investigator_full_name": "Dr. Decleer Wim", 
            "investigator_title": "gynecologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The number of patients with an ongoing first trimester pregnancy", 
            "measure": "pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "AZ Jan Palfijn Gent", 
        "sponsors": {
            "collaborator": {
                "agency": "Onze Lieve Vrouw  Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "AZ Jan Palfijn Gent", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}